GlobeNewswire Inc | Nov 22, 2021 12:37PM EST

November 22, 2021

CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology therapies, today announced that it will be participating in the 4th Annual Evercore ISI HealthconX Conference from November 30th to December 2nd, 2021.

Nadim Ahmed, Cullinans Chief Executive Officer, will participate in a virtual fireside chat on Wednesday December 1st, 2021 at 2:15pm ET.

Management will also be participating in one-on-one investor meetings throughout the conference. Investors interested in scheduling a meeting with Cullinans management should contact their Evercore representative.

About Cullinan Oncology

Cullinan Oncology is a biopharmaceutical company with a diversified pipeline of targeted therapeutic candidates across multiple modalities. The Companys strategy is to focus on advanced stage assets with novel technology platforms and differentiated mechanisms, developed through both internal discovery and external collaboration. Learn more about Cullinan at www.cullinanoncology.com.

Contacts:

Investor Relationsinvestors@cullinanoncology.com

Jeffrey Trigilio+1 617.410.4650jtrigilio@cullinanoncology.com